Article
The NAD(P)H:quinone oxidoreductase I C609T polymorphism modifies the risk of Barrett esophagus and esophageal adenocarcinoma.
Genetics in medicine : official journal of the American College of Medical Genetics - 1 Jun 2007
di Martino Erica, Hardie Laura J, Wild Christopher P, Gong Yun Y, Olliver Joanna R, Gough Martin D, Bird Nigel C
Abstract excerpt
PURPOSE: The role of genetic susceptibility to esophageal adenocarcinoma and its precursor lesion Barrett esophagus has not been fully elucidated. This study investigated the effect of polymorphisms in the manganese superoxide dismutase (MnSOD) and NAD(P)H:quinone oxidoreductase 1 (NQO1) genes in modulating the risk of developing Barrett esophagus or esophageal adenocarcinoma. METHODS: A total of 584 patients...
Topics
- Adenocarcinoma
- Adult
- Aged
- Aged, 80 and over
- Barrett Esophagus
- Esophageal Neoplasms
- Esophagitis, Peptic
- Female
- Genetic Predisposition to Disease
- Humans
